EE200100320A - 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod - Google Patents

6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod

Info

Publication number: EE200100320A
Authority: EE; Estonia
Prior art keywords: preparation; composition; receptor labeling; azauracil derivatives; organ visualization
Prior art date: 1998-12-18

Application number

EEP200100320A

Other languages

English (en)

Estonian (et)

Inventor

Jean Edgard Freyne Eddy

Dirk Deroose Frederik

Fernand Armand Lacrampe Jean

Constant Johan Embrechts Werner

Michel Claude Fortin Jerome

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-18

Filing date

1999-12-16

Publication date

2002-10-15

1999-12-16 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2002-10-15 Publication of EE200100320A publication Critical patent/EE200100320A/xx

Links

238000000034 method Methods 0.000 title 2
238000002360 preparation method Methods 0.000 title 2
SSPYSWLZOPCOLO-UHFFFAOYSA-N 6-azauracil Chemical class O=C1C=NNC(=O)N1 SSPYSWLZOPCOLO-UHFFFAOYSA-N 0.000 title 1
238000002372 labelling Methods 0.000 title 1
210000000056 organ Anatomy 0.000 title 1
238000007794 visualization technique Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EEP200100320A 1998-12-18 1999-12-16 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod EE200100320A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98204336		1998-12-18
PCT/EP1999/010169 WO2000037451A1 (en)	1998-12-18	1999-12-16	Il-5 inhibiting 6-azauracil derivatives

Publications (1)

Publication Number	Publication Date
EE200100320A true EE200100320A (et)	2002-10-15

Family

ID=8234494

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100320A EE200100320A (et)	1998-12-18	1999-12-16	6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod

Country Status (35)

Country	Link
US (1)	US6803364B1 (de)
EP (1)	EP1140873B1 (de)
JP (1)	JP2002533331A (de)
KR (1)	KR100635721B1 (de)
CN (1)	CN100343239C (de)
AR (1)	AR021887A1 (de)
AT (1)	ATE365723T1 (de)
AU (1)	AU773780B2 (de)
BG (1)	BG105602A (de)
BR (1)	BR9916366A (de)
CA (1)	CA2354511A1 (de)
CO (1)	CO5150147A1 (de)
CZ (1)	CZ20012062A3 (de)
DE (1)	DE69936396T2 (de)
DK (1)	DK1140873T3 (de)
EA (1)	EA004806B1 (de)
EE (1)	EE200100320A (de)
ES (1)	ES2289835T3 (de)
HK (1)	HK1042491A1 (de)
HR (1)	HRP20010455A2 (de)
HU (1)	HUP0104641A3 (de)
ID (1)	ID28880A (de)
IL (1)	IL143766A (de)
MY (1)	MY125808A (de)
NO (1)	NO319814B1 (de)
NZ (1)	NZ512748A (de)
PL (1)	PL198205B1 (de)
PT (1)	PT1140873E (de)
SA (1)	SA00201030B1 (de)
SK (1)	SK8152001A3 (de)
TR (1)	TR200101729T2 (de)
TW (1)	TWI249530B (de)
UA (1)	UA73107C2 (de)
WO (1)	WO2000037451A1 (de)
ZA (1)	ZA200104942B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8466096B2 (en) *	2007-04-26	2013-06-18	Afton Chemical Corporation	1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
RU2523651C2 (ru) *	2012-05-22	2014-07-20	Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО ВГМУ Минздравсоцразвития России)	Способ дифференцированного контроля базисного противовоспалительного лечения бронхиальной астмы у детей и подростков
RU2506045C1 (ru) *	2012-09-05	2014-02-10	Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН	Способ прогнозирования достижения контроля бронхиальной астмы
CN119161311B (zh) *	2024-11-20	2025-02-11	北京纳百生物科技有限公司	一种地克珠利抗原及其合成方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2149645A1 (de)	1970-10-07	1972-09-14	Pfizer	2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
US3912723A (en)	1971-03-29	1975-10-14	Pfizer	2-Phenyl-as-triazine-3,5(2H,4H)diones
US3883528A (en)	1974-04-19	1975-05-13	Pfizer	Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats
US4631278A (en)	1984-08-01	1986-12-23	Janssen Pharmaceutica N.V.	Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
CA1244024A (en)	1984-08-01	1988-11-01	Gustaaf M. Boeckx	.alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en)	1986-01-30	1986-03-05	Janssen Pharmaceutica Nv	5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
CA1331757C (en)	1988-02-29	1994-08-30	Janssen Pharmaceutica Naamloze Vennootschap	5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
EP0476439A1 (de)	1990-09-18	1992-03-25	Bayer Ag	Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
DE4120138A1 (de)	1991-06-19	1992-12-24	Bayer Ag	Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
TW263495B (de)	1992-12-23	1995-11-21	Celltech Ltd
GB9304920D0 (en)	1993-03-10	1993-04-28	Celltech Ltd	Chemical compounds
TW403741B (en)	1993-10-15	2000-09-01	Takeda Chemical Industries Ltd	Triazine derivative, production and use thereof
TW332201B (en)	1995-04-06	1998-05-21	Janssen Pharmaceutica Nv	1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
DE69615601T2 (de)	1995-04-14	2002-07-11	Takeda Schering-Plough Animal Health K.K., Osaka	Verfahren zur Herstellung von Triazinderivate
CN1128141C (zh) *	1996-08-30	2003-11-19	武田舍林-普劳动物保健株式会社	1,2,4－三嗪－3,5－二酮衍生物,其制备和用途
BR9811678A (pt) *	1997-07-10	2000-09-19	Janssen Pharmaceutica Nv	Derivados de 6-azauracila de inibição de il-5
HRP990333A2 (en) *	1997-07-10	2000-04-30	Janssen Pharmaceutica Nv	6-azauracil derivatives as il-5 inhibitors

1999
- 1999-12-16 PL PL349526A patent/PL198205B1/pl not_active IP Right Cessation
- 1999-12-16 DK DK99965509T patent/DK1140873T3/da active
- 1999-12-16 JP JP2000589523A patent/JP2002533331A/ja not_active Withdrawn
- 1999-12-16 EP EP99965509A patent/EP1140873B1/de not_active Expired - Lifetime
- 1999-12-16 HK HK02104206.0A patent/HK1042491A1/zh unknown
- 1999-12-16 ID IDW00200101295A patent/ID28880A/id unknown
- 1999-12-16 CN CNB998146110A patent/CN100343239C/zh not_active Expired - Fee Related
- 1999-12-16 IL IL14376699A patent/IL143766A/xx not_active IP Right Cessation
- 1999-12-16 EA EA200100677A patent/EA004806B1/ru not_active IP Right Cessation
- 1999-12-16 DE DE69936396T patent/DE69936396T2/de not_active Expired - Fee Related
- 1999-12-16 HR HR20010455A patent/HRP20010455A2/hr not_active Application Discontinuation
- 1999-12-16 BR BR9916366-7A patent/BR9916366A/pt not_active Application Discontinuation
- 1999-12-16 AU AU21001/00A patent/AU773780B2/en not_active Ceased
- 1999-12-16 SK SK815-2001A patent/SK8152001A3/sk unknown
- 1999-12-16 KR KR1020017006666A patent/KR100635721B1/ko not_active Expired - Fee Related
- 1999-12-16 NZ NZ512748A patent/NZ512748A/en unknown
- 1999-12-16 US US09/868,384 patent/US6803364B1/en not_active Expired - Fee Related
- 1999-12-16 CA CA002354511A patent/CA2354511A1/en not_active Abandoned
- 1999-12-16 UA UA2001075132A patent/UA73107C2/uk unknown
- 1999-12-16 AT AT99965509T patent/ATE365723T1/de not_active IP Right Cessation
- 1999-12-16 ES ES99965509T patent/ES2289835T3/es not_active Expired - Lifetime
- 1999-12-16 EE EEP200100320A patent/EE200100320A/xx unknown
- 1999-12-16 PT PT99965509T patent/PT1140873E/pt unknown
- 1999-12-16 CZ CZ20012062A patent/CZ20012062A3/cs unknown
- 1999-12-16 TR TR2001/01729T patent/TR200101729T2/xx unknown
- 1999-12-16 HU HU0104641A patent/HUP0104641A3/hu unknown
- 1999-12-16 WO PCT/EP1999/010169 patent/WO2000037451A1/en not_active Ceased
- 1999-12-17 CO CO99079022A patent/CO5150147A1/es unknown
- 1999-12-17 MY MYPI99005536A patent/MY125808A/en unknown
- 1999-12-17 TW TW088122197A patent/TWI249530B/zh not_active IP Right Cessation
- 1999-12-17 AR ARP990106512A patent/AR021887A1/es not_active Application Discontinuation
2000
- 2000-03-05 SA SA00201030A patent/SA00201030B1/ar unknown
2001
- 2001-06-14 BG BG105602A patent/BG105602A/xx unknown
- 2001-06-15 NO NO20012987A patent/NO319814B1/no unknown
- 2001-06-15 ZA ZA200104942A patent/ZA200104942B/en unknown

Also Published As

Publication number	Publication date
CA2354511A1 (en)	2000-06-29
PT1140873E (pt)	2007-10-10
CN1330643A (zh)	2002-01-09
ATE365723T1 (de)	2007-07-15
SA00201030B1 (ar)	2006-10-11
ID28880A (id)	2001-07-12
EP1140873B1 (de)	2007-06-27
JP2002533331A (ja)	2002-10-08
ZA200104942B (en)	2002-06-18
HRP20010455A2 (en)	2002-06-30
NO20012987D0 (no)	2001-06-15
AU773780B2 (en)	2004-06-03
PL198205B1 (pl)	2008-06-30
HUP0104641A2 (hu)	2002-04-29
EP1140873A1 (de)	2001-10-10
HUP0104641A3 (en)	2003-01-28
US6803364B1 (en)	2004-10-12
NO20012987L (no)	2001-08-17
NZ512748A (en)	2004-05-28
IL143766A0 (en)	2002-04-21
AR021887A1 (es)	2002-08-07
HK1042491A1 (zh)	2002-08-16
SK8152001A3 (en)	2002-04-04
DK1140873T3 (da)	2007-10-15
BG105602A (en)	2002-01-31
DE69936396D1 (de)	2007-08-09
CN100343239C (zh)	2007-10-17
CO5150147A1 (es)	2002-04-29
KR100635721B1 (ko)	2006-10-17
TR200101729T2 (tr)	2001-10-22
NO319814B1 (no)	2005-09-19
EA004806B1 (ru)	2004-08-26
BR9916366A (pt)	2001-09-18
KR20010080617A (ko)	2001-08-22
IL143766A (en)	2005-11-20
DE69936396T2 (de)	2008-06-19
MY125808A (en)	2006-08-30
WO2000037451A1 (en)	2000-06-29
TWI249530B (en)	2006-02-21
CZ20012062A3 (cs)	2002-03-13
ES2289835T3 (es)	2008-02-01
UA73107C2 (en)	2005-06-15
AU2100100A (en)	2000-07-12
EA200100677A1 (ru)	2001-12-24

Publication	Publication Date	Title
EE05021B1 (et)	2008-06-16	Enterokattega ravimkoostis ja selle valmistamise meetod
EE200000707A (et)	2002-04-15	Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200000016A (et)	2000-10-16	IL-5 inhibeerivad 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, retseptori markeerimismeetod ja organi visualiseerimismeetod
EE04739B1 (et)	2006-12-15	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod
BR9814340B1 (pt)	2010-07-13	compostos derivados de indol, processo para a preparação dos mesmo e composição farmacêutica.
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE05086B1 (et)	2008-10-15	Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
EE04499B1 (et)	2005-06-15	A1-adenosiiniretseptori agonistid, nende valmistamismeetod ja kasutamine
EE03568B1 (et)	2001-12-17	Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
EE03263B1 (et)	2000-04-17	Erütromütsiini derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja vaheühendid
NO20012058D0 (no)	2001-04-26	2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
EE04275B1 (et)	2004-04-15	Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
FI963272A7 (fi)	1996-08-21	Uusi indolijohdannaisia, jotka ovat käyttökelpoisia hoitamaan estrogee niin liittyviä kasvaimia ja sairauksia
EE04489B1 (et)	2005-06-15	Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
EE9500064A (et)	1996-06-17	Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE03338B1 (et)	2001-02-15	Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
CY2013003I2 (el)	2015-08-05	Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
BR9611675A (pt)	1999-02-23	Processo para preparação de uma composição de asfalto
EE9800265A (et)	1999-02-15	Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
FI962969L (fi)	1996-07-25	Indolijohdannaisia 5-HT1:n agonisteina
EE9900112A (et)	1999-10-15	2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200000651A (et)	2002-04-15	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200300153A (et)	2003-06-16	Östrogeeni retseptori modulaatorid, farmatseutiline kompositsioon ja selle valmistamismeetod
NO995097L (no)	1999-10-19	Fremgangsmåte for fremstilling av en asfaltsammensetning
EE200100320A (et)	2002-10-15	6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod